Brisbane, California — According to state and local economic development sources Freenome plans to build out 335,460 square feet of new space in Brisbane. The company plans to occupy the new space at 3000 Marina Blvd. in Brisbane, on or about February 1, 2023. According to the company website Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent cancer. We have pioneered the most comprehensive multiomics platform for early cancer detection through a routine blood draw. By combining deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Societys BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.

To learn more about Freenome, visit http://www.freenome.com/

Company Contact:
Mike Nolan, Chief Executive Officer
https://www.linkedin.com/in/mike-nolan-6b41b041/
650-446-6630

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved